Story not found
This article may have been removed or the link is incorrect.
← Return to briefing
events
FDA expands Mounjaro approval for heart attack and stroke prevention
Summary by Waco Editorial Desk Scripps News Group , as published by KXXV
· August 31, 2026
· 1 min read
Photo: KXXV · view original
Story provenance No corrections
Summary created by Waco Editorial Desk — automated, rule-governed Byline on source page Scripps News Group, as published by KXXV Original story Read at the source Source published Aug 31, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway The medication's manufacturer views this expansion as a significant step forward in reducing the risk of heart disease, a leading cause of death for people with type 2 diabetes.
High-risk adults with type 2 diabetes may benefit from an expanded use of a certain medication. The drug, produced by Eli Lilly, has been approved to help prevent heart attacks and strokes. This development builds on the medication's existing record.
Further information is available on the details of this approval and its implications for adults with type 2 diabetes. The medication's manufacturer views this expansion as a significant step forward in reducing the risk of heart disease, a leading cause of death for people with type 2 diabetes.
Why this story is here
KXXV reported and published this story. Waco selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by KXXV . Waco selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KXXV . Have a tip or correction? Contact the editor .
Category: events Published: August 31, 2026 Source: KXXV Reading time: 1 min
Frequently asked about this story
What is this story about? High-risk adults with type 2 diabetes may benefit from an expanded use of a certain medication. The drug, produced by Eli Lilly, has been approved to help prevent heart attacks and strokes. This…
When was this published? This article was first published on August 31, 2026 by KXXV and curated for Waco readers.
Who reported this story? This story was reported by Scripps News Group at KXXV. To learn more about how Waco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more events coverage from Waco, or browse our daily briefing and topic hubs .
← Back to all news
More events →
Today’s briefing
Subscribe to newsletter
Continue reading
This preview is provided by Waco News. Full article available at
